These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12825956)

  • 1. A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors.
    Sabatino G; Chinol M; Paganelli G; Papi S; Chelli M; Leone G; Papini AM; De Luca A; Ginanneschi M
    J Med Chem; 2003 Jul; 46(14):3170-3. PubMed ID: 12825956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry.
    Uppal JK; Varshney R; Hazari PP; Chuttani K; Kaushik NK; Mishra AK
    J Drug Target; 2011 Jul; 19(6):418-26. PubMed ID: 20678008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests.
    Pratesi A; Bucelli F; Mori I; Chinol M; Verdoliva A; Paganelli G; Rivieccio V; Gariboldi L; Ginanneschi M
    J Med Chem; 2010 Jan; 53(1):432-40. PubMed ID: 19928962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a DOTA--biotin conjugate for radionuclide chelation via Cu-free click chemistry.
    Schultz MK; Parameswarappa SG; Pigge FC
    Org Lett; 2010 May; 12(10):2398-401. PubMed ID: 20423109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers.
    Pratesi A; Ginanneschi M; Melani F; Chinol M; Carollo A; Paganelli G; Lumini M; Bartoli M; Frediani M; Rosi L; Petrucci G; Messori L; Papini AM
    Org Biomol Chem; 2015 Apr; 13(13):3988-4001. PubMed ID: 25722026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT).
    Urbano N; Papi S; Ginanneschi M; De Santis R; Pace S; Lindstedt R; Ferrari L; Choi S; Paganelli G; Chinol M
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):68-77. PubMed ID: 16755333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding.
    James S; Maresca KP; Allis DG; Valliant JF; Eckelman W; Babich JW; Zubieta J
    Bioconjug Chem; 2006; 17(3):579-89. PubMed ID: 16704194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies.
    Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Nilsson R; Sandberg BE; Brechbiel M
    Bioconjug Chem; 2002; 13(5):1079-92. PubMed ID: 12236790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-labeling of biotin analogues and their characterization.
    Blom E; Långström B; Velikyan I
    Bioconjug Chem; 2009 Jun; 20(6):1146-51. PubMed ID: 19453100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target visualization by MRI using the avidin/biotin amplification route: synthesis and testing of a biotin-Gd-DOTA monoamide trimer.
    Tei L; Barge A; Geninatti Crich S; Pagliarin R; Negri V; Ramella D; Cravotto G; Aime S
    Chemistry; 2010 Jul; 16(27):8080-7. PubMed ID: 20533461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and stability of the [
    Roy T; Pogorilyy E; Kumarananthan CP; Kvitastein UA; Foscato M; Törnroos KW; Adamsen TCH; Le Roux E
    Chem Commun (Camb); 2024 Jul; 60(56):7148-7151. PubMed ID: 38860653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
    J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability.
    Wilbur DS; Hamlin DK; Chyan MK; Kegley BB; Pathare PM
    Bioconjug Chem; 2001; 12(4):616-23. PubMed ID: 11459467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a DOTA-lysine-biotin conjugate as an effector molecule for pretargeted radionuclide therapy.
    Hainsworth J; Harrison P; Mather SJ
    Bioconjug Chem; 2005; 16(6):1468-74. PubMed ID: 16287243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
    Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
    J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3.
    Chang F; Qu T; Rusckowski M; Hnatowich DJ
    Appl Radiat Isot; 1999 Apr; 50(4):723-32. PubMed ID: 10101833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.
    Barge A; Cappelletti E; Cravotto G; Ferrigato A; Lattuada L; Marinoni F; Tei L
    Org Biomol Chem; 2009 Sep; 7(18):3810-6. PubMed ID: 19707687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelators for radioimmunotherapy: I. NMR and ab initio calculation studies on 1,4,7,10-tetra(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO4Pr) and 1,4,7-tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO3A1Pr).
    Keire DA; Jang YH; Li L; Dasgupta S; Goddard WA; Shively JE
    Inorg Chem; 2001 Aug; 40(17):4310-8. PubMed ID: 11487337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates.
    Liu S; Pietryka J; Ellars CE; Edwards DS
    Bioconjug Chem; 2002; 13(4):902-13. PubMed ID: 12121149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astatine-211-labeled biotin conjugates resistant to biotinidase for use in pretargeted radioimmunotherapy.
    Foulon CF; Alston KL; Zalutsky MR
    Nucl Med Biol; 1998 Feb; 25(2):81-8. PubMed ID: 9468020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.